A Substantive Due Process Problem to the War on Medications
If there is a 20 year patent on these drugs then "Humira" is likely to be priced out of achieve of the general public until 2023 that has been a massive revenue taking screen for congressional representatives. "Skyrizi" that will be new in 2010 in 2019 is listed around "$15,000" for a one year equipment that is 5 or 6 shots. "Humira" is procedure and product form. "Skyrizi" eliminates 90% of...
0 Comments 0 Shares